We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

167 hedge funds and large institutions have $708M invested in Spectrum Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 73 increasing their positions, 37 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 37

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

1% more funds holding

Funds holding: 165 → 167 (+2)

3% less capital invested

Capital invested by funds: $733M → $708M (-$25.3M)

73% less call options, than puts

Call options by funds: $3.81M | Put options by funds: $14M

Holders
167
Holders Change
+2
Holders Change %
+1.21%
% of All Funds
3.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
73
Reduced
37
Closed
19
Calls
$3.81M
Puts
$14M
Net Calls
-$10.1M
Net Calls Change
+$3.1M

Top Buyers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
+$6.94M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$6.6M
3
BlackRock
BlackRock
New York
+$5.4M
4
Macquarie Group
Macquarie Group
Australia
+$3.54M
5
VOYA Investment Management
VOYA Investment Management
Georgia
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$6.43M
2
State Street
State Street
Massachusetts
-$6.2M
3
Deutsche Bank
Deutsche Bank
Germany
-$4.74M
4
Morgan Stanley
Morgan Stanley
New York
-$3.36M
5
Marshall Wace
Marshall Wace
United Kingdom
-$2.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$151M +$5.4M +668,060 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$106M +$6.6M +815,850 +7%
Primecap Management
3
Primecap Management
California
$91M -$1.21M -150,200 -1%
ACH
4
ArrowMark Colorado Holdings
Colorado
$38.5M +$6.94M +857,480 +23%
State Street
5
State Street
Massachusetts
$36M -$6.2M -766,323 -15%
Macquarie Group
6
Macquarie Group
Australia
$28.1M +$3.54M +437,829 +15%
Renaissance Technologies
7
Renaissance Technologies
New York
$22.9M +$313K +38,700 +1%
Norges Bank
8
Norges Bank
Norway
$20.1M – – –
Fidelity Investments
9
Fidelity Investments
Massachusetts
$17.2M -$1.62K -200 -0%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$12.2M +$464K +57,310 +4%
Northern Trust
11
Northern Trust
Illinois
$12M +$1.24M +153,859 +12%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$10.9M +$690K +85,345 +7%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$10.1M +$43.2K +5,344 +0.4%
VOYA Investment Management
14
VOYA Investment Management
Georgia
$8.6M +$1.56M +192,846 +23%
CS
15
Candriam SCA
Luxembourg
$8.44M -$404K -50,000 -5%
Principal Financial Group
16
Principal Financial Group
Iowa
$7.66M +$319K +39,411 +4%
Wells Fargo
17
Wells Fargo
California
$5.8M +$236K +29,228 +4%
SIM
18
Sonora Investment Management
Arizona
$5.72M -$89K -11,005 -2%
Charles Schwab
19
Charles Schwab
California
$5.6M +$316K +39,003 +6%
Invesco
20
Invesco
Georgia
$5.55M -$581K -71,795 -10%
SCM
21
Sio Capital Management
New York
$5.13M +$121K +15,000 +2%
Ameriprise
22
Ameriprise
Minnesota
$4.96M +$39.5K +4,886 +0.8%
Morgan Stanley
23
Morgan Stanley
New York
$4.48M -$3.36M -414,893 -43%
SIG
24
Sargent Investment Group
Maryland
$4.44M +$592K +73,240 +16%
PAM
25
Panagora Asset Management
Massachusetts
$4.14M -$619K -76,580 -13%
1
2 3 4 5

SPPI Hedge Fund Activity: Q3 2019 in Review

167 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2019, worth a combined $708M — down 3.4% from $733M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SPPI positions and 19 closed out — a net gain of 2 holders — while 73 added to existing stakes and 37 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $6.94M. The largest seller was Citadel Advisors, cutting an estimated $6.43M.

  • 167 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2019, up from 165 in Q2 2019.
  • Funds reported $708M of Spectrum Pharmaceuticals Inc stock for Q3 2019, down 3.4% quarter-over-quarter.
  • 21 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2019 and 19 closed out, a net change of +2 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2019 was ArrowMark Colorado Holdings, an estimated $6.94M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2019 was Citadel Advisors, an estimated $6.43M sold.

Based on aggregated 13F filings for Q3 2019.